摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-methyl-4-iso-propyl-4H-oxazolin-5-one | 78654-98-5

中文名称
——
中文别名
——
英文名称
2-methyl-4-iso-propyl-4H-oxazolin-5-one
英文别名
2-methyl-4-isopropyl-2-oxazolin-5-one;4-isopropyl-2-methyloxazol-5(4H)-one;2-methyl-4-isopropyl-5-oxazolone;4-isopropyl-2-methyl-4H-oxazol-5-one;4-Isopropyl-2-methyl-4H-oxazol-5-on;5-Oxo-2-methyl-4-propyl-Δ2-oxazolin;4-Isopropyl-2-methyl-1,3-oxazol-5(4H)-one;2-methyl-4-propan-2-yl-4H-1,3-oxazol-5-one
2-methyl-4-iso-propyl-4H-oxazolin-5-one化学式
CAS
78654-98-5
化学式
C7H11NO2
mdl
——
分子量
141.17
InChiKey
VSYHWTNTZROWMJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.71
  • 拓扑面积:
    38.7
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    2-methyl-4-iso-propyl-4H-oxazolin-5-one氢溴酸 作用下, 以 四氢呋喃硝基甲烷 为溶剂, 反应 7.0h, 生成 N-乙酰-D-缬氨酸
    参考文献:
    名称:
    对映体纯的环状和开放链(R)-和(S)-α,α-二取代α-氨基酸的新通用方法
    摘要:
    制备了各种各样的环状和开链α,α-二取代的α-氨基酸1a-p。通过与衍生自(S)-苯丙氨酸的手性胺15-18偶联,拆分外消旋N-酰化的α,α-二取代氨基酸,形成非对映异构体19/20或21/22,可以通过结晶和/或快速色谱分离在硅胶上(方案3)。通过1,3-恶唑-5(4 H)-酮10a-p的选择性裂解以高收率得到相应的光学纯α,α-二取代氨基酸衍生物11或12(方案3)。α,α-二取代氨基酸的绝对构型由非对映异构体20、21g',22d的X射线结构确定。
    DOI:
    10.1002/hlca.19920750522
  • 作为产物:
    描述:
    氯乙酰基-DL-缬氨酸 在 palladium dichloride sodium benzoate氢气苯甲酸酐三乙胺 作用下, 反应 6.0h, 生成 2-methyl-4-iso-propyl-4H-oxazolin-5-one
    参考文献:
    名称:
    Asymmetric synthesis of amino acids by catalytic reduction of azlactones of substituted acylaminoacrylic acids. 8. Reductive aminolysis of 4-isopropylidene-oxazol-5-ones
    摘要:
    DOI:
    10.1007/bf00963427
点击查看最新优质反应信息

文献信息

  • [EN] BENZAMIDE TRPA1 ANTAGONISTS<br/>[FR] BENZAMIDES ANTAGONISTES DE TRPA1
    申请人:ACTURUM LIFE SCIENCE AB
    公开号:WO2014184235A1
    公开(公告)日:2014-11-20
    Compounds of formula I, pharmaceutically acceptable salts thereof, diastereomers, enantiomers, or mixtures thereof: wherein R, X, Y, Z, n and A are as defined in the specification, as well as pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
    式I的化合物,其药用盐,非对映体,对映体或其混合物:其中R、X、Y、Z、n和A的定义如规范中所述,以及包括这些化合物的药物组合物已经准备好。它们在治疗中很有用,特别是在疼痛管理中。
  • PREPARATION OF 5-TRIMETHYLSILOXYOXAZOLES FROM 2-OXAZOLIN-5-ONES AND THEIR DIELS–ALDER REACTION: SYNTHESIS OF VITAMIN B<sub>6</sub>DERIVATIVES
    作者:Hidetsugu Takagaki、Nobuyoshi Yasuda、Morio Asaoka、Hisashi Takei
    DOI:10.1246/cl.1979.183
    日期:1979.2.5
    of 2-oxazolin-5-ones using chlorotrimethylsilane and triethylamine in high yields. Diels–Alder reaction of the siloxyoxazoles with N-phenylmaleinimide or dimethyl maleate afforded the corresponding substituted pyridines in high yields. This method was applied to the synthesis of Vitamin B6 derivatives starting from N-formylalanine.
    通过使用三甲基氯硅烷和三乙胺对 2-恶唑啉-5-酮进行硅烷化反应,以高产率合成了各种 5-三甲基甲硅烷氧基恶唑。甲硅烷氧基恶唑与 N-苯基马来酰亚胺或马来酸二甲酯的 Diels-Alder 反应以高产率提供了相应的取代吡啶。该方法适用于以 N-甲酰丙氨酸为原料合成维生素 B6 衍生物。
  • Diastereochemical Diversity of Imidazoline Scaffolds via Substrate Controlled TMSCl Mediated Cycloaddition of Azlactones
    作者:Vasudha Sharma、Jetze J. Tepe
    DOI:10.1021/ol052118w
    日期:2005.10.1
    We report herein a trimethylsilyl chloride mediated substrate controlled 1,3-dipolar cycloaddition for the diastereoselective synthesis of either syn- or anti-imidazolines. This method provides scaffolds with four points of diversity and control over two stereocenters.
  • N-1-Alkyl-2-oxo-2-aryl amides as novel antagonists of the TRPA1 receptor
    作者:Karl S.A. Vallin、Karin J. Sterky、Eva Nyman、Jenny Bernström、Rebecka From、Christian Linde、Alexander B.E. Minidis、Andreas Nolting、Katja Närhi、Ellen M. Santangelo、Fernando W. Sehgelmeble、Daniel Sohn、Jennie Strindlund、Dirk Weigelt
    DOI:10.1016/j.bmcl.2012.07.032
    日期:2012.9
    A series of potent antagonists of the ion channel transient receptor potential A1 (TRPA1) was developed by modifying lead structure 16 that was discovered by high-throughput screening. Based on lead compound 16, a SAR was established, showing a narrow region at the nitro-aromatic R-1 moiety and at the warhead, while the R-2 side had a much wider scope including ureas and carbamates. Compound 16 inhibits Ca2+-activated TRPA1 currents reversibly in whole cell patch clamp experiments, indicating that under in vivo conditions, it does not react covalently, despite its potentially electrophilic ketone. (c) 2012 Elsevier Ltd. All rights reserved.
  • Study of a new ‘chiral proton’ organocatalyst with hydrolase activity: application in azlactone racemic dynamic resolution
    作者:Ángel L. Fuentes de Arriba、Omayra H. Rubio、Luis Simón、Victoria Alcázar、Laura M. Monleón、Francisca Sanz、Joaquin R. Morán
    DOI:10.1016/j.tetasy.2017.04.012
    日期:2017.6
    For the first time, a 1,3-ketoenol system is described as an acid catalyst with hydrolytic activity. The combination of an enol and a pyridine/benzimidazole supported on a benzofuran skeleton allowed the creation of a novel bifunctional organocatalyst, which has been applied in azlactone racemic dynamic resolution. In spite of the moderate enantioselectivities obtained, the catalyst constitutes a novel concept in the field of chiral Brensted acid catalysis. (C) 2017 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物